Eli Lilly Surges with a 45% Revenue Jump to $12.7 Billion in Q1, Fueled by Weight-Loss and Diabetes Drugs
Eli Lilly's Q1 revenue soared by 45% to $12.73 billion, thanks to strong sales of Mounjaro and Zepbound. The company also reported a net income of $2.76 billion, up 23% YoY, and an...
